×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
16136 views

Programme

18:00
Pourquoi les chirurgiens doivent favoriser les traitements néo-adjuvants ?
Pr Fabien Reyal
 
18:20
Prise en charge des patientes métastatiques synchrones
Pr Jean-Yves Pierga

18:40 Prise en charge des récidives régionales isolées
Dr Sarah Differding
 
19:00 Débat/discussion - Réponses aux questions

 
Réunion modérée par Pr Fabien Reyal

Shooting date : 2021-04-14
Last update : 2022-12-19
2 comments
Join the Discussion
  • Delphine M. Oui je suis là!!!

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Kheloudja B. les tumeurs de 2 cm ou plus HER2 surexprimé , reçoivent une chimiothérapie néoadjuavnte et si pas de yp0yPn0 , du TDM 1 en adjuvant . que disent les données sur les tumemeurs HER2+ qui ne reçoivent de néoadj car petites de taille qui au final recevront herception en adjuvant mais ne connaissant pas leur sensibilité au néoadj , est ce que celles qui n'auraient pas répondu ne rateraient pas le bénéfice du TDM1 en adjuvant , pourquoi pas du néoadj pour toutes lees HER2+?

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      0
      Days
      0
      Hours
      0
      Minutes
      0
      Seconds
      Tuesday, November 19th 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Tuesday, November 19th 2024 from 07am to 08:30am (GMT+1)
      San Francisco : Tuesday, November 19th 2024 from 09am to 10:30am (GMT+1)
      New York : Tuesday, November 19th 2024 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Tuesday, November 19th 2024 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Tuesday, November 19th 2024 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Tuesday, November 19th 2024 from 06pm to 07:30pm (GMT+1)
      Istanbul : Tuesday, November 19th 2024 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Tuesday, November 19th 2024 from 09pm to 10:30pm (GMT+1)
      Bangkok : Wednesday, November 20th 2024 from 12am to 01:30am (GMT+1)
      Shanghai : Wednesday, November 20th 2024 from 01am to 02:30am (GMT+1)
      Tokyo : Wednesday, November 20th 2024 from 02am to 03:30am (GMT+1)
      Sydney : Wednesday, November 20th 2024 from 03am to 04:30am (GMT+1)
      Wellington : Wednesday, November 20th 2024 from 05am to 06:30am (GMT+1)

      Cancer du sein métastatique RH+/HER2- :

      individualisation du traitement en 1ère et 2ème ligne

      Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
      Honolulu : Thursday, October 14th 2021 from 07am to 08am (GMT+2)
      San Francisco : Thursday, October 14th 2021 from 10am to 11am (GMT+2)
      New York : Thursday, October 14th 2021 from 01pm to 02pm (GMT+2)
      Buenos Aires : Thursday, October 14th 2021 from 02pm to 03pm (GMT+2)
      Reykjavik : Thursday, October 14th 2021 from 05pm to 06pm (GMT+2)
      London / Dublin : Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
      Paris / Berlin : Thursday, October 14th 2021 from 07pm to 08pm (GMT+2)
      Istanbul : Thursday, October 14th 2021 from 08pm to 09pm (GMT+2)
      Moscou / Dubaï : Thursday, October 14th 2021 from 09pm to 10pm (GMT+2)
      Bangkok : Friday, October 15th 2021 from 12am to 01am (GMT+2)
      Shanghai : Friday, October 15th 2021 from 01am to 02am (GMT+2)
      Tokyo : Friday, October 15th 2021 from 02am to 03am (GMT+2)
      Sydney : Friday, October 15th 2021 from 04am to 05am (GMT+2)
      Wellington : Friday, October 15th 2021 from 06am to 07am (GMT+2)

      Le cancer du sein métastatique HER2 +, standards actuels et orientations futures

      Octobre Rose 2021

      Share
      Thursday, December 2nd 2021 from 06pm to 07pm (GMT+1)
      Honolulu : Thursday, December 2nd 2021 from 07am to 08am (GMT+1)
      San Francisco : Thursday, December 2nd 2021 from 09am to 10am (GMT+1)
      New York : Thursday, December 2nd 2021 from 12pm to 01pm (GMT+1)
      Buenos Aires : Thursday, December 2nd 2021 from 02pm to 03pm (GMT+1)
      London / Dublin : Thursday, December 2nd 2021 from 05pm to 06pm (GMT+1)
      Paris / Berlin : Thursday, December 2nd 2021 from 06pm to 07pm (GMT+1)
      Istanbul : Thursday, December 2nd 2021 from 07pm to 08pm (GMT+1)
      Moscou / Dubaï : Thursday, December 2nd 2021 from 09pm to 10pm (GMT+1)
      Bangkok : Friday, December 3rd 2021 from 12am to 01am (GMT+1)
      Shanghai : Friday, December 3rd 2021 from 01am to 02am (GMT+1)
      Tokyo : Friday, December 3rd 2021 from 02am to 03am (GMT+1)
      Sydney : Friday, December 3rd 2021 from 03am to 04am (GMT+1)
      Wellington : Friday, December 3rd 2021 from 05am to 06am (GMT+1)

      SLNB or TAD after NAC in cN1 / ycN0 patients

      Share
      Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
      Honolulu : Wednesday, May 10th 2023 from 07am to 08:30am (GMT+2)
      San Francisco : Wednesday, May 10th 2023 from 10am to 11:30am (GMT+2)
      New York : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT+2)
      Buenos Aires : Wednesday, May 10th 2023 from 02pm to 03:30pm (GMT+2)
      Reykjavik : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+2)
      London / Dublin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
      Paris / Berlin : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+2)
      Istanbul : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+2)
      Moscou / Dubaï : Wednesday, May 10th 2023 from 09pm to 10:30pm (GMT+2)
      Bangkok : Thursday, May 11th 2023 from 12am to 01:30am (GMT+2)
      Shanghai : Thursday, May 11th 2023 from 01am to 02:30am (GMT+2)
      Tokyo : Thursday, May 11th 2023 from 02am to 03:30am (GMT+2)
      Sydney : Thursday, May 11th 2023 from 04am to 05:30am (GMT+2)
      Wellington : Thursday, May 11th 2023 from 06am to 07:30am (GMT+2)

      Cancer du sein : actualités et essais en cours, vers où allons-nous ?

      Share
      Scroll Up